Endosomal pH environment

The endosomal pH environment refers to the tightly regulated acidic conditions found within the lumen of endocytic organelles, which gradually drops from approximately pH 6.5 in early endosomes to pH 5.0-5.5 in late endosomes and lysosomes [1]. This acidification is primarily driven by the Vacuolar-type H+-ATPase (V-ATPase), an ATP-dependent proton pump, and is essential for basic cellular processes such as the dissociation of ligands from internalized receptors, the activation of acid-sensitive hydrolases, and the sorting of cargo for recycling or degradation [2]. Beyond its physiological roles, the acidic environment of the endosome is a critical gateway for many intracellular pathogens; for instance, many enveloped viruses exploit the low pH to trigger conformational changes in viral glycoproteins that facilitate membrane fusion and genome release into the host cytoplasm [3]. In the context of pharmacology, the endosomal pH environment is a key factor in drug delivery and the mechanism of action for several classes of therapeutic agents. Lysosomotropic drugs like chloroquine and hydroxychloroquine are weak bases that selectively accumulate in acidic compartments, where they become protonated and trapped, effectively neutralizing the acidity and inhibiting pH-dependent viral entry or autophagy-mediated survival in cancer cells [4][5]. However, because maintaining pH gradients is fundamental to almost all cell types, systemic modulation of endosomal pH poses significant therapeutic challenges, including potential interference with normal proteostasis and cellular homeostasis [6].

Other names

Endosomal acidificationEndosomal pHLuminal pHEndosomal milieu

Modulation of endosomal pH typically occurs via two mechanisms: the accumulation of lysosomotropic weak bases (e.g., chloroquine) which sequester protons and increase pH, or the direct inhibition of the Vacuolar-type H+-ATPase (V-ATPase) proton pump (e.g., bafilomycin A1), preventing the translocation of hydrogen ions into the lumen.